ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,222.79
0.53%
Dow Jones
39,164.06
0.09%
Gold vs US Dollar
2,336.26
0.36%
Brent Oil
85.755
0.40%
Bitcoin
61,427.94
-0.29%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC

  6. Daiichi Sankyo Company Ltd (PK) (DSNKY) Share Price

DSNKY Daiichi Sankyo Company Ltd (PK)

34.26
0.00 (0.00%)
28 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Daiichi Sankyo Company Ltd (PK) USOTC:DSNKY OTCMarkets Depository Receipt  Sponsored ADR Level I Japan
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 34.26 34.16 34.69 0.00 0.00   10:33:46   
 Type  Size  Price  Time  Units 
   0.00  
 
Recent News
DateTimeSource
HeadlineMore DSNKY News
23/10/202307:49DJNAstraZeneca, Daiichi Sankyo's Enhertu Gets Approval in EU For Lung Cancer Treatment
20/10/202301:30DJNMerck, Daiichi Sankyo Ink Commercialization Deal for Up to $22 Billion
22/09/202307:53DJNAstraZeneca Says Trial Results For Breast Cancer Drug Were Highly Positive
15/09/202315:51DJNAstraZeneca's Lung-Cancer Treatment Gets Recommended for Approval in the EU
11/09/202307:55DJNAstraZeneca Says Datopotamab Deruxtecan Combined With Imfinzi Shows High Disease Control Rates
03/07/202307:50DJNAstraZeneca Says Datopotamab Deruxtecan Phase 3 Trial Shows Positive Results in Lung Cancer Patients
Period
Draw mode
Data Downloads for DSNKY

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Daiichi Sankyo Company Ltd (PK) Articles